Gain Therapeutics, Inc. — Director's Dealing 2021

Dec 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gain Therapeutics, Inc. (GANX)
CIK: 0001819411
Period of Report: 2021-12-23

Reporting Person: Alder Matthias (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-23	Non Qualified Stock Option (right to buy)	$5.86	A	200000	Acquired	2032-10-15	Common Stock (200000)	Direct

Footnotes

F1: 50,000 options shall vest on 10/15/2022 (the "Initial Vesting Date") and the remaining 150,000 options shall vest in a series of thirty-six (36) successive equal monthly installments on each subsequent monthly anniversary of the Initial Vesting Date.